Robyn Goforth, PhD

Robyn Goforth, PhD
As Vice President Technology Assessment at VIC, Dr. Goforth leads technical and commercial evaluation of technologies ranging from medical devices to pharmaceuticals as well as scientific research tools and instrumentation. Dr. Goforth also serves as Chief Scientific Officer of VIC portfolio company, BiologicsMD ™

Recent Posts

Behind the Curtain: Opportunity Assessment at VIC

Behind the Curtain: Opportunity Assessment at VIC

Posted by December 10, 2019

Ask ten people how best to assess the value of a new technology, and you’ll likely get ten different answers. Google "opportunity assessment", and you will find hundreds of different templates, worksheets, and...

Read More
All posts

FEATURED RESOURCES

Newspaper
Updates
VIC Tech Announces New Class of Fellows
glasses-solid
Insight
Our Life Science and Healthcare Future
lightbulb-regular
White Paper
Portfolio Diversification in Times of Market Volatility
microphone-alt-solid
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
glasses-solid
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
lightbulb-regular
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
bullhorn-solid
News
Solenic Medical, Inc. Announces $5.1M Series A Funding Round Led by Johnson & Johnson Innovation – JJDC, Inc.
microphone-alt-solid
Interview
VIC Fellows Spotlight: Matthew Leming, PhD
chalkboard-teacher-solid
From The Corner Office
From the Corner Office: Michael Artinger, PhD – CEO of Solaris Vaccines, Inc.

Technology Solutions For A Better World

Our mission is to form and grow life science and emerging technology companies that shape the future by bringing innovative discoveries from research labs to commercial deployment.

Subscribe to the VIC newsletter.

Privacy Policy